Bayer Articles
Sanofi/B-MS publish Plavix trial design
10 November 2008
Stock Commentary - Europe - week to Nov 3, 2008
10 November 2008
Actavis opens R&D laboratory in Florida
10 November 2008
Bayer/Onyx' Nexavar boosts OS 44% in HCC
10 November 2008
EFPIA "regrets" delay in EC pharma proposals
10 November 2008
Stock Commentary - Europe - week to Oc 27, 2008
3 November 2008
Bayer's Andreas Resch quits
3 November 2008
UK scientists pave way to predicting pre-eclampsia
3 November 2008
ImmunoGen licenses TAP technology rights to Bayer
27 October 2008
Promising Ph II data for Genzyme/Bayer's alemtuzumab
27 October 2008
CLARIFICATION: Genzyme's Campath Ph II trial results
27 October 2008
Bayer licenses Sartorius' UVivatec
27 October 2008
Novartis to acquire Nektar unit for $115M
27 October 2008
Court of Appeal upholds 2005 Barr/Cipro decision
27 October 2008
Bayer delists from Tokyo exchange
20 October 2008
Stock Commentary - Europe - week to Oct 13, 2008
20 October 2008
Mylan Europe projects double-digit growth
20 October 2008
Bayer's Factor VIII drug gets FDA go-ahead
20 October 2008
Daiichi Sankyo plans to become a leader in antithrombotics with prasugrel and DU-176b
20 October 2008
Stock Commentary - Europe - week to Oct 6, 2008
13 October 2008
BioXcel views next phase of growth
13 October 2008
NSAIDs reduce breast cancer link 21%
13 October 2008
Expert updates on current CF pipeline
13 October 2008
Bayer's riociguat to enters Ph III testing
13 October 2008
Bayer HealthCare eyeing acquisitions
13 October 2008
Bayer gets European approval for Xarelto
6 October 2008
Cell Thera submits sBLA for Zevalin as first-line therapy
6 October 2008
Stock Commentary - Europe - week to Sept 29, 2008
6 October 2008
Activaero and Bayer join forces for inhaled therapies
6 October 2008
Bayer to make bios in tobacco plants
6 October 2008
FDA and Indevus agree over Nebido NDA
6 October 2008
Regeneron and Bayer present wet AMD data
6 October 2008
Nomad Bioscience in licensing deal with Bayer/Icon
6 October 2008
Bayer data encourages early MS treatment
29 September 2008
Intendis licenses Photonamic's 5-ALA patch
29 September 2008
Paracetamol linked to asthma risk
29 September 2008
Bayer chooses Bernd Halling as permanent head for Liaison Office
22 September 2008
Stock Commentary - Europe - week to Sept 15, 2008
22 September 2008
Pfizer economic study says Sutent cost effective in mRCC
22 September 2008
Bayer tops most-visited European pharma web sites
22 September 2008
Bayer Healthcare acquires Direvo Biotech in 210 million-euro cash deal
22 September 2008
FDA approves Talecris' orphan drug for CIDP
22 September 2008
Bayer Schering licenses novel PET tracers
15 September 2008
Bayer shares up on rumored Pfizer takeover
15 September 2008
Stock Commentary - Europe - week to Sept 8, 2008
15 September 2008
EPIX regains Vasovist rights from Bayer
15 September 2008
Early use of Merck & Co's Aggrastat benefits STEMI patients
8 September 2008
Bayer Schering submits European marketing application for Recothrom
8 September 2008
Wyeth appoints Daniel McIntyre as VP of corporate communications
8 September 2008
Stock Commentary - Europe - week to Sept 1, 2008
8 September 2008
USA's Consumer Reports warns pain pills can worsen headaches
8 September 2008
Promising mid-stage data on apixaban in ACS
8 September 2008
Bayer/Onyx initiate Ph III Nexavar trial in liver cancer
1 September 2008
Recurrent events 35% less likely with prasugrel than Plavix
1 September 2008
Strong Ph III data on Javelin's Dyloject
1 September 2008
PDCO gives word on PIPs from latest meeting
1 September 2008
Bayer signs deal to supply contraceptives to developing nations
1 September 2008
US FDA set for even fewer approvals in 2008
1 September 2008
52-week improvements with VEGF Trap-Eye
1 September 2008
Onyx back in profit for 2nd qtr after sales jump
1 September 2008
Barr's 2nd-qtr 2008 profit rises 27%
18 August 2008
Cell Therapeutics recruits Craig Philips as president
18 August 2008
Boehringer's first-half 2008 profit drops 10%
18 August 2008
Boehringer's first-half 2008 profit drops 10%
18 August 2008
Bayer names Greg Babe as new US CEO
11 August 2008
Stock Commentary - Europe - week to Aug 4, 2008
11 August 2008
UK cancer charity slams NICE methods
11 August 2008
Intellego expands expertise with Zenosis acquisition
11 August 2008
Bayer's 2nd-qtr 2008 net profit falls 13%
11 August 2008
J&J/Bayer's anticoagulant submitted for approval in USA
4 August 2008
Levitra benefits prostatectomy patients
4 August 2008
Bayer/J&J's Xarelto gets nod from CHMP
4 August 2008
Stock Commentary - Europe - week to July 28m 2008
4 August 2008
Lilly's 2nd-qtr rise hides coming challenges
4 August 2008
Bayer/Onyx' Nexavar cleared for HCC in China
4 August 2008
EMEA proposes limiting use of Bayer's moxifloxacin
4 August 2008
Praziquantel may help slow HIV/AIDS transmission
28 July 2008
US FDA approves Bayer Schering's Primovist
21 July 2008
Stock Commentary - Europe - week to July7, 2008
14 July 2008
Black box warnings on fluoroquinolone
14 July 2008
Bayer publishes Leukine trial results
14 July 2008
Bayer buys Maxygen portfolio for $120M
7 July 2008
Bayer pools RECORD trial data for report
7 July 2008
Xarelto could set new gold standard in VTE
7 July 2008
Stock Commentary - Europe - week to June 23, 2008
30 June 2008
Bayer to overtake AZ in Chinese Rx market?
30 June 2008
Bayer enters generic Yasmin deal with Barr
30 June 2008
EFPIA celebrates 30 years of achievements
30 June 2008
Bayer opens plant-made drugs facility
23 June 2008
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
